The over-expression of e2f-1 in non-small cell lung cancer can activate the expressions of thymidylate synthase and survivin, and then encourage the proliferation of tumors, finally resulting in the worse prognosis [23]. Here, BIRC5 is linked to non-small cell lung carcinoma.